$MDXG News
Last published 5d ago
- 5d agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior...
- 5d agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the following
- 2w agoMDXGThird Quarter 2026 Operating & Financial Results Conference Call - MIMEDX GROUP INCEarnings Call TranscriptsGreetings and welcome to the MiMedx third quarter 2026 operating financial results conference call. At this time all participants are in a listen only mode. A question and answer session will follow the formal presentati
- 2w agoMDXGThird Quarter 2026 Operating & Financial Results Conference Call - MIMEDX GROUP INCEarnings Call TranscriptsGreetings and welcome to the MiMedx third quarter 2026 operating financial results conference call. At this time all participants are in a listen only mode. A question and answer session will follow the formal presentati
- 2w agoMDXGMIMEDX GROUP, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
- 2w agoMDXGMIMEDX Announces Third Quarter 2026 Operating & Financial ResultsGlobeNewswireReports Continued Double-Digit Year-Over-Year Volume Growth for Surgical Franchise Delivers Wound Care Center Volume Growth Both Sequentially and Year-Over-Year Obtained Favorable Federal Court Ruling in AXIOFILL®
- 2w agoMDXGMIMEDX Announces $25 Million Patent License AgreementGlobeNewswireMARIETTA, Ga., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it has entered into a license agreement with a wound care competitor
- 4w agoMDXGMIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026GlobeNewswireMARIETTA, Ga., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the third
- 2mo agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the following
- 3mo agoMDXGSMTIMIMEDX Announces Second Quarter 2026 Operating & Financial ResultsGlobeNewswireReports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30
- 3mo agoMDXGSMTIMIMEDX to Acquire Sanara MedTechGlobeNewswireTransformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical
- 3mo agoMDXGMIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29GlobeNewswireMARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the second
- 4mo agoCNXUIARTMDXGORGO+1Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild ItselfGlobeNewswireIssued on behalf of Conexeu Sciences Inc. A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit
- 4mo agoCNXUIARTMDXGORGO+1The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding ItGlobeNewswireIssued on behalf of Conexeu Sciences Inc. A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow
- 5mo agoCNXUIARTBVSORGO+1The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement PartsPR NewswireFor more than half a century, the answer to lost tissue has been to manufacture a substitute and put it where the tissue used to be. Replace, don't...
- 5mo agoMDXGMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor ConferenceGlobeNewswireMARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the Craig-Hallum 23rd Annual
- 6mo agoMDXGMIMEDX Announces Launch of G4Derm® PlusGlobeNewswireFlowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc.
- 6mo agoACRXANIKAXGNBEAT+6TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesGlobeNewswireMALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced a
- 6mo agoMDXGMIMEDX Announces First Quarter 2026 Operating & Financial ResultsGlobeNewswireReports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations Management to Host Conference Call Today, April 29, 2026, at 4:30 PM ET MARIETTA, Ga., April 29, 2026
- 6mo agoMDXGMIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29GlobeNewswireMARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the first quarter ended March
- 6mo agoMDXGMIMEDX Announces Restructuring and Cost Reduction InitiativeGlobeNewswireMARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced a series of cost reduction initiatives intended to prioritize growth opportunities,
- 7mo agoMDXGMIMEDX to Sponsor Leading Advanced Wound Care ConferencesGlobeNewswireMultispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- MiMedx
- 7mo agoMDXGMIMEDX Announces Launch of CHORIOFIX™GlobeNewswireMARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the commercial launch of CHORIOFIX™, the latest advanced wound care innovation in
- 8mo agoMDXGMIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid ShieldsGlobeNewswireMARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension of the
- 8mo agoMDXGMIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial ResultsGlobeNewswireNet Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted EBITDA1 was $29
- 8mo agoMDXGMIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25GlobeNewswireMARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the fourth quarter and full year
- 9mo agoMDXGMIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound ProductsGlobeNewswireMARIETTA, Ga., Feb. 04, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Summit Products Group ("Summit") to
- 9mo agoMDXGMIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®GlobeNewswireMARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the 15th anniversary of EPIFIX and AMNIOFIX, the Company's placental allografts used in
- 10mo agoMDXGMIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound GelGlobeNewswireMARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to distribute their
- 10mo agoMDXGMIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In VitroGlobeNewswireMARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the latest addition to its industry-leading body of scientific and clinical evidence
- 12mo agoMDXGMIMEDX Provides Update on EPIEFFECT® Randomized Controlled TrialGlobeNewswirePublication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to Standard of Care ("SOC") Publication Adds to Large Compendium of
- 1y agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the following investor
- 1y agoMDXGMIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final RuleGlobeNewswireMARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today commented on the Centers for Medicare and Medicaid Services ("CMS") release of the CY 2026 Physician
- 1y agoMDXGMIMEDX Announces Record Revenue for Third Quarter 2025GlobeNewswireSecond Consecutive Quarter of Highest Quarterly Net Sales in MIMEDX History Third Quarter Net Sales of $114 million Grew 35% Year-Over-Year Third Quarter GAAP Net Income and Diluted Earnings Per Share were $17
- 1y agoMDXGMIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29GlobeNewswireMARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the third quarter ended
- 1y agoMDXGMIMEDX Announces Launch of EPIXPRESS®GlobeNewswireMARIETTA, Ga., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the launch of EPIXPRESS®, the Company's newest addition to its portfolio of AWC
- 1y agoMDXGMIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) FallGlobeNewswireMARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place
- 1y agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the following investor
- 1y agoMDXGMiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoMDXGMIMEDX Announces Record Second Quarter 2025 Operating and Financial ResultsGlobeNewswireHighest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06, Respectively
- 1y agoMDXGMIMEDX Announces Strategic Collaboration with Vaporox, Inc.GlobeNewswireMARIETTA, Ga., July 30, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointly announced a collaboration, whereby the companies will co-promote
- 1y agoMDXGMIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30GlobeNewswireMARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the second quarter ended June
- 1y agoMDXGMIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026GlobeNewswireMARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today commented on the Centers for Medicare and Medicaid Services ("CMS") release of the CY 2026 Physician
- 1y agoMDXGMIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswireMARIETTA, Ga., May 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the following investor conferences:
- 1y agoMDXGMIMEDX to Present at the BofA Securities 2025 Healthcare ConferenceGlobeNewswireMARIETTA, Ga., May 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that members of its senior management will participate in the BofA Securities 2025 Healthcare
- 1y agoMDXGMIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)GlobeNewswireMARIETTA, Ga., May 05, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced the publication of its health economics data for reconstruction of cutaneous wounds with
- 1y agoMDXGMIMEDX Announces First Quarter 2025 Operating and Financial ResultsGlobeNewswireNet Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA was $17
- 1y agoMDXGMIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30GlobeNewswireMARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the first quarter ended March
- 1y agoMDXGMIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry ConferencesGlobeNewswireMARIETTA, Ga., April 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it will participate in the following industry conferences this quarter to feature the
- 1y agoMDXGMIMEDX to Present at TD Cowen 45th Annual Health Care ConferenceGlobeNewswireMARIETTA, Ga., Feb. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that senior management will participate in the TD Cowen 45th Annual Health Care Conference.